IGC Pharma Wins 2 Awards in Phase 1 of NIA’S AI PREPARE Challenge, Advancing Alzheimer’s Early Prediction Research October 1, 2024 Read More »
IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer’s Treatment September 18, 2024 Read More »
IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer’s Disease September 4, 2024 Read More »